Melanomas
REPOSIT (Principal investigator: dr. A.J.M. van den Eertwegh)
A Phase II, Open-Label, Multicenter Study of Vemurafenib plus Cobimetinib (GDC-0973) in Unresectable Stage IIIc or Stage IV Melanoma -Response Monitoring and Resistance Prediction with Positron Emission Tomography and Tumor Characteristics.
Zirconipi (Principal investigator: dr. A.J.M. van den Eertwegh)
Uptake and biodistribution of 89Zirconium-labeled ipilimumab in ipilimumab treated patients with metastic melanoma.
Masterkey-265 (Principal investigator: dr. A.J.M. van den Eertwegh)
A Phase 1b/3, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With Pembrolizumab (MK-3475) for Treatment of Unresected, Stage IIIB to IVM1c Melanoma.